FREE ELECTRONIC LIBRARY - Dissertations, online materials

Pages:     | 1 |   ...   | 7 | 8 || 10 | 11 |   ...   | 16 |


-- [ Page 9 ] --

109. Gurnell,M., Wentworth,J.M., Agostini,M., Adams,M., Collingwood,T.N., Provenzano,C., Browne,P.O., Rajanayagam,O., Burris,T.P., Schwabe,J.W., Lazar,M.A., and Chatterjee,V.K. (2000) A dominantnegative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis. J.Biol.Chem., 275, 5754-5759.

110. Gupta,R.A., Brockman,J.A., Sarraf,P., Willson,T.M., and DuBois,R.N.

(2001) Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells. J.Biol.Chem., 276, 29681-29687.

111. Lee,J.C., Kumar,S., Griswold,D.E., Underwood,D.C., Votta,B.J., and Adams,J.L. (2000) Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology, 47, 185-201.

112. Ahmad,N., Adhami,V.M., Afaq,F., Feyes,D.K., and Mukhtar,H. (2001) Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells.

Clin.Cancer Res., 7, 1466-1473.

113. She,Q.B., Bode,A.M., Ma,W.Y., Chen,N.Y., and Dong,Z. (2001) Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res., 61, 1604-1610.

114. Brakenhielm,E., Cao,R., and Cao,Y. (2001) Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J., 15, 1798-1800.

–  –  –

116. Urdiales,J.L., Medina,M.A., and Sanchez-Jimenez,F. (2001) Polyamine metabolism revisited. Eur.J.Gastroenterol.Hepatol., 13, 1015-1019.

117. Roux,P.P. and Blenis,J. (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Microbiol.Mol.Biol.Rev., 68, 320-344.

118. Dhillon,A.S., Hagan,S., Rath,O., and Kolch,W. (2007) MAP kinase signalling pathways in cancer. Oncogene, 26, 3279-3290.

119. Puri,P.L., Wu,Z., Zhang,P., Wood,L.D., Bhakta,K.S., Han,J., Feramisco,J.R., Karin,M., and Wang,J.Y. (2000) Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev., 14, 574-584.

120. Bulavin,D.V., Phillips,C., Nannenga,B., Timofeev,O., Donehower,L.A., Anderson,C.W., Appella,E., and Fornace,A.J., Jr. (2004) Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway.

Nat.Genet., 36, 343-350.

121. Deacon,K., Mistry,P., Chernoff,J., Blank,J.L., and Patel,R. (2003) p38 Mitogen-activated protein kinase mediates cell death and p21-activated kinase mediates cell survival during chemotherapeutic drug-induced mitotic arrest. Mol.Biol.Cell, 14, 2071-2087.

122. Losa,J.H., Parada,C.C., Viniegra,J.G., Sanchez-Arevalo,L., V, Cajal,S., and Sanchez-Prieto,R. (2003) Role of the p38 MAPK pathway in cisplatin-based therapy. Oncogene, 22, 3998-4006.

123. Boldt,S., Weidle,U.H., and Kolch,W. (2002) The role of MAPK pathways in the action of chemotherapeutic drugs. Carcinogenesis, 23, 1831-1838.

124. Kong,J.Y., Klassen,S.S., and Rabkin,S.W. (2005) Ceramide activates a mitochondrial p38 mitogen-activated protein kinase: a potential mechanism for loss of mitochondrial transmembrane potential and apoptosis. Mol.Cell Biochem., 278, 39-51.

125. Pru,J.K., Hendry,I.R., Davis,J.S., and Rueda,B.R. (2002) Soluble Fas ligand activates the sphingomyelin pathway and induces apoptosis in luteal steroidogenic cells independently of stress-activated p38(MAPK).

Endocrinology, 143, 4350-4357.

126. Spiegelman,B.M., Hu,E., Kim,J.B., and Brun,R. (1997) PPAR gamma and the control of adipogenesis. Biochimie, 79, 111-112.

127. Rodriguez,J.C., Gil-Gomez,G., Hegardt,F.G., and Haro,D. (1994) Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J.Biol.Chem., 269, 18767-18772.

–  –  –

128. Wang,M. and Tafuri,S. (2003) Modulation of PPARgamma activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis. J.Cell Biochem., 89, 38-47.

129. Su,C.G., Wen,X., Bailey,S.T., Jiang,W., Rangwala,S.M., Keilbaugh,S.A., Flanigan,A., Murthy,S., Lazar,M.A., and Wu,G.D. (1999) A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J.Clin.Invest, 104, 383-389.

130. Ricote,M., Li,A.C., Willson,T.M., Kelly,C.J., and Glass,C.K. (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature, 391, 79-82.

131. Mossner,R., Schulz,U., Kruger,U., Middel,P., Schinner,S., Fuzesi,L., Neumann,C., and Reich,K. (2002) Agonists of peroxisome proliferatoractivated receptor gamma inhibit cell growth in malignant melanoma.

J.Invest Dermatol., 119, 576-582.

132. Yang,W.L. and Frucht,H. (2001) Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells.

Carcinogenesis, 22, 1379-1383.

133. Zang,C., Liu,H., Posch,M.G., Waechter,M., Facklam,M., Fenner,M.H., Ruthardt,M., Possinger,K., Phillip,K.H., and Elstner,E. (2004) Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia. Leuk.Res., 28, 387-397.

134. Sarraf,P., Mueller,E., Smith,W.M., Wright,H.M., Kum,J.B., Aaltonen,L.A., de la,C.A., Spiegelman,B.M., and Eng,C. (1999) Loss-of-function mutations in PPAR gamma associated with human colon cancer.

Mol.Cell, 3, 799-804.

135. Puigserver,P., Wu,Z., Park,C.W., Graves,R., Wright,M., and Spiegelman,B.M. (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell, 92, 829-839.

136. Glass,C.K. and Rosenfeld,M.G. (2000) The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev., 14, 121-141.

137. Chawla,S., Hardingham,G.E., Quinn,D.R., and Bading,H. (1998) CBP: a signal-regulated transcriptional coactivator controlled by nuclear calcium and CaM kinase IV. Science, 281, 1505-1509.

138. Puigserver,P., Rhee,J., Lin,J., Wu,Z., Yoon,J.C., Zhang,C.Y., Krauss,S., Mootha,V.K., Lowell,B.B., and Spiegelman,B.M. (2001) Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol.Cell, 8, 971-982.

–  –  –

140. Puigserver,P. and Spiegelman,B.M. (2003) Peroxisome proliferatoractivated receptor-gamma coactivator 1 alpha (PGC-1 alpha):

transcriptional coactivator and metabolic regulator. Endocr.Rev., 24, 78Borra,M.T., Smith,B.C., and Denu,J.M. (2005) Mechanism of human SIRT1 activation by resveratrol. J.Biol.Chem., 280, 17187-17195.

142. Vaziri,H., Dessain,S.K., Ng,E.E., Imai,S.I., Frye,R.A., Pandita,T.K., Guarente,L., and Weinberg,R.A. (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell, 107, 149-159.

143. Rodgers,J.T., Lerin,C., Haas,W., Gygi,S.P., Spiegelman,B.M., and Puigserver,P. (2005) Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature, 434, 113-118.

144. Picard,F., Kurtev,M., Chung,N., Topark-Ngarm,A., Senawong,T., Machado,D.O., Leid,M., McBurney,M.W., and Guarente,L. (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPARgamma. Nature, 429, 771-776.

145. Eyster,K.M. (2007) The membrane and lipids as integral participants in signal transduction: lipid signal transduction for the non-lipid biochemist.

Adv.Physiol Educ., 31, 5-16.

146. Fernandis,A.Z. and Wenk,M.R. (2007) Membrane lipids as signaling molecules. Curr.Opin.Lipidol., 18, 121-128.

147. Serhan,C.N., Haeggstrom,J.Z., and Leslie,C.C. (1996) Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J., 10, 1147-1158.

148. Huwiler,A., Kolter,T., Pfeilschifter,J., and Sandhoff,K. (2000) Physiology and pathophysiology of sphingolipid metabolism and signaling.

Biochim.Biophys.Acta, 1485, 63-99.

149. Lin,C.F., Chen,C.L., and Lin,Y.S. (2006) Ceramide in apoptotic signaling and anticancer therapy. Curr.Med.Chem., 13, 1609-1616.

150. Pettus,B.J., Chalfant,C.E., and Hannun,Y.A. (2002) Ceramide in apoptosis: an overview and current perspectives. Biochim.Biophys.Acta, 1585, 114-125.

151. Sandhoff,K., Kolter,T., and Echten-Deckert,G. (1998) Sphingolipid metabolism. Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell. Ann.N.Y.Acad.Sci., 845, 139-151.

152. Senchenkov,A., Litvak,D.A., and Cabot,M.C. (2001) Targeting ceramide metabolism--a strategy for overcoming drug resistance. J.Natl.Cancer Inst., 93, 347-357.

–  –  –

153. Huwiler,A. and Zangemeister-Wittke,U. (2007) Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy. Crit Rev.Oncol.Hematol., 63, 150-159.

154. Reynolds,C.P., Maurer,B.J., and Kolesnick,R.N. (2004) Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett., 206, 169-180.

155. Flamigni,F., Faenza,I., Marmiroli,S., Stanic',I., Giaccari,A., Muscari,C., Stefanelli,C., and Rossoni,C. (1997) Inhibition of the expression of ornithine decarboxylase and c-Myc by cell-permeant ceramide in difluoromethylornithine-resistant leukaemia cells. Biochem.J., 324 ( Pt 3), 783-789.

156. Augenlicht,L.H., Wadler,S., Corner,G., Richards,C., Ryan,L., Multani,A.S., Pathak,S., Benson,A., Haller,D., and Heerdt,B.G. (1997) Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial. Cancer Res., 57, 1769Pena,A., Reddy,C.D., Wu,S., Hickok,N.J., Reddy,E.P., Yumet,G., Soprano,D.R., and Soprano,K.J. (1993) Regulation of human ornithine decarboxylase expression by the c-Myc.Max protein complex.

J.Biol.Chem., 268, 27277-27285.

158. Kee,K., Vujcic,S., Merali,S., Diegelman,P., Kisiel,N., Powell,C.T., Kramer,D.L., and Porter,C.W. (2004) Metabolic and antiproliferative consequences of activated polyamine catabolism in LNCaP prostate carcinoma cells. J.Biol.Chem., 279, 27050-27058.

159. Malumbres,M. and Barbacid,M. (2001) To cycle or not to cycle: a critical decision in cancer. Nat.Rev.Cancer, 1, 222-231.

160. Massague,J. (2004) G1 cell-cycle control and cancer. Nature, 432, 298Sherr,C.J. (2000) The Pezcoller lecture: cancer cell cycles revisited.

Cancer Res., 60, 3689-3695.

162. Ortega,S., Malumbres,M., and Barbacid,M. (2002) Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim.Biophys.Acta, 1602, 73-87.

163. Hanahan,D. and Weinberg,R.A. (2000) The hallmarks of cancer. Cell, 100, 57-70.

164. Kim,D.K., Baek,J.H., Kang,C.M., Yoo,M.A., Sung,J.W., Chung,H.Y., Kim,N.D., Choi,Y.H., Lee,S.H., and Kim,K.W. (2000) Apoptotic activity of ursolic acid may correlate with the inhibition of initiation of DNA replication. Int.J.Cancer, 87, 629-636.

–  –  –

165. Li,J., Guo,W.J., and Yang,Q.Y. (2002) Effects of ursolic acid and oleanolic acid on human colon carcinoma cell line HCT15. World J.Gastroenterol., 8, 493-495.

166. Mazumder,S., Gong,B., and Almasan,A. (2000) Cyclin E induction by genotoxic stress leads to apoptosis of hematopoietic cells. Oncogene, 19, 2828-2835.

167. Lawrence,T.S., Davis,M.A., and Loney,T.L. (1996) Fluoropyrimidinemediated radiosensitization depends on cyclin E-dependent kinase activation. Cancer Res., 56, 3203-3206.

168. Mazumder,S., DuPree,E.L., and Almasan,A. (2004) A dual role of cyclin E in cell proliferation and apoptosis may provide a target for cancer therapy. Curr.Cancer Drug Targets., 4, 65-75.

169. Mazumder,S., Plesca,D., and Almasan,A. (2007) A jekyll and hyde role of cyclin E in the genotoxic stress response: switching from cell cycle control to apoptosis regulation. Cell Cycle, 6, 1437-1442.

170. Koga,H., Harada,M., Ohtsubo,M., Shishido,S., Kumemura,H., Hanada,S., Taniguchi,E., Yamashita,K., Kumashiro,R., Ueno,T., and Sata,M. (2003) Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells. Hepatology, 37, 1086-1096.

171. Reed,J.C. (2006) Proapoptotic multidomain Bcl-2/Bax-family proteins:

mechanisms, physiological roles, and therapeutic opportunities. Cell Death.Differ., 13, 1378-1386.

172. Perlman,H., Zhang,X., Chen,M.W., Walsh,K., and Buttyan,R. (1999) An elevated bax/bcl-2 ratio corresponds with the onset of prostate epithelial cell apoptosis. Cell Death.Differ., 6, 48-54.

173. Raisova,M., Hossini,A.M., Eberle,J., Riebeling,C., Wieder,T., Sturm,I., Daniel,P.T., Orfanos,C.E., and Geilen,C.C. (2001) The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fasmediated apoptosis. J.Invest Dermatol., 117, 333-340.

174. Ashkenazi,A. and Dixit,V.M. (1998) Death receptors: signaling and modulation. Science, 281, 1305-1308.

175. Yagita,H., Takeda,K., Hayakawa,Y., Smyth,M.J., and Okumura,K. (2004) TRAIL and its receptors as targets for cancer therapy. Cancer Sci., 95, 777-783.

176. Altucci,L., Rossin,A., Raffelsberger,W., Reitmair,A., Chomienne,C., and Gronemeyer,H. (2001) Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL.

Nat.Med., 7, 680-686.

–  –  –

proteins regulate type I interferon-induced apoptosis in multiple myeloma. Blood, 98, 2183-2192.

178. Oshima,K., Yanase,N., Ibukiyama,C., Yamashina,A., Kayagaki,N., Yagita,H., and Mizuguchi,J. (2001) Involvement of TRAIL/TRAIL-R interaction in IFN-alpha-induced apoptosis of Daudi B lymphoma cells.

Cytokine, 14, 193-201.

179. Gerner,E.W. and Meyskens,F.L., Jr. (2004) Polyamines and cancer: old molecules, new understanding. Nat.Rev.Cancer, 4, 781-792.

180. Wallace,H.M. and Fraser,A.V. (2004) Inhibitors of polyamine metabolism:

review article. Amino.Acids, 26, 353-365.

Pages:     | 1 |   ...   | 7 | 8 || 10 | 11 |   ...   | 16 |

Similar works:

«Aus der Klinik für Augenheikunde Der Universität zu Lübeck Direktor: Prof. Dr. med. H. Laqua Development of a New Lubricant and Nutrient Tear Substitute Inauguraldissertation zur Erlangung der Doktorwürde Der Universität zu Lübeck Aus der Medizinischen Fakultät Vorgelegt von LIU Lei Aus Dandong Lübeck 2004 1. Berichterstatter:2. Berichterstatter:Tag der mündlichen Prüfung: Zum Druck genehmigt: Lübeck, den TABLE OF CONTENTS 1 INTRODUCTION 1.1 THE OCULAR SURFACE 1.1.1 Anatomy of the...»

«FP7-REGPOT – 2012-2013 Grant agreement No: 316254 BASTION „From Basic to Translational Research in Oncology Project start date: 01.09.2012 Duration: 36 months (Project) 6 months (Evaluation) Coordinator: Department of Immunology, Medical University of Warsaw, 02-091 Warsaw, Poland Project Coordinator: Prof. Jakub Golab Tel: +48 22 599 01 99 E-mail: jakub.golab@wum.edu.pl Deliverable 6.7 Preliminary conclusions and recommendations from the IAB Document Information: Project founded by the...»

«Reprint from: Laterality, 1999, 4(3): 197-208 Twinning and Embryonic Left-Right Asymmetry Michael Levin Bldg. C1, 5th floor Cell Biology dept. Harvard Medical School 240 Longwood Ave. Boston, MA 02115 U.S.A. Tel. (617) 432-0044 Fax. (617) 432-1144 Email: levin@whiz.med.harvard.edu Keywords: twins, left-right, asymmetry, conjoined, chirality Running title: Twinning and LR Asymmetry Twinning and LR Asymmetry Introduction The geometrical invariance known as symmetry is a striking feature of...»

«JASON ROBERTS School Visit 2011 TASTY RECIPE BOOK Your body is an awesome machine! Strong healthy bodies need good fuel. JASON ROBERTS Celebrity Chef, Author and TV Personality Jason has been captivating audiences world wide with his high energy and health conscious cooking. Jason’s enthusiasm for good basic cooking has been likened to British Chef Jamie Oliver. Finding inspiration in his Nana’s kitchen as a child, Jason said, ‘Nana, I want to be a cook!’. Jason has been working closely...»

«WHA62/2009/REC/1 WORLD HEALTH ORGANIZATION SIXTY-SECOND WORLD HEALTH ASSEMBLY GENEVA, 18–22 MAY 2009 RESOLUTIONS AND DECISIONS ANNEXES GENEVA RESOLUTIONS Prevention of avoidable blindness and visual impairment1 WHA62.1 The Sixty-second World Health Assembly, Having considered the report and draft action plan on the prevention of avoidable blindness and visual impairment;2 Recalling resolutions WHA56.26 on elimination of avoidable blindness and WHA59.25 on prevention of avoidable blindness and...»

«SF-DCT INFORMATION FOR OVERLAP SYNDROME (OS) CLAIMS OPTION 1 (OS Claims are not eligible for Disease Option 2) 1 OVERLAP SYNDROME (OS) The diagnosis of Overlap Syndrome (OS) is applied when features of Systemic Sclerosis (Scleroderma) (skler-a-DER-ma) appear in conjunction with one or more other connective tissue diseases. In the Dow Corning Plan, Overlap Syndrome requires the diagnosis of either Systemic Lupus Erythematosus (SLE) Inflammatory Muscle Disease or Rheumatoid Arthritis (RA), PLUS...»

«Chapter 16 The NIH Anticonvulsant Drug Development (ADD) Program: preclinical anticonvulsant screening project James P. Stables and Harvey J. Kupferberg Epilepsy Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA Summary Summary reports are written for those compounds that have undergone multilevel evaluations. A report analyzes and interprets the generated data, and also compares the candidate compound's pharmacodynamic and...»


«drtanandpartners.com Understanding Sexually Transmitted Diseases A Guidebook to Better Sexual Health (MEN) Introduction The aim of this book is to shed light onto how STIs affect men, and sexual health and their well-being. We hope to use this book as a guide to educate our readers on the symptoms of STIs. It is important to go for screening develop any symptoms. Being diagnosed and treated early helps prevent future complications. We always believe in promoting greater sexual health knowledge,...»

«Report ‘Global cause’ and effect How the aid system is undermining the Millennium Development Goals Introduction There is a genuine risk that the human development related Millennium Development Goals (MDGs) will not be met if international donors continue to pursue single issue ‘global causes’ instead of building an aid system that will respond to the complex needs of poor communities. Progress in health and education is dependent on access to affordable sanitation and safe water. And...»

«H.E. Paltul Rinpoche • The Medicine Buddha Puja long practice of the Kagyu tradition From the Sky Dharma, which is a Mind Treasure, An Ornament of the Clear Expanse of Mind, Comes a Ritual of Menla Called A Stream of Lapis Lazuli Namo. Maha Bekandzeya. If they are available, arrange in front of a Menla thangka as many peaceful offerings as you can, such as a mandala and so forth; in this way the accumulations are completed. If these are not available, it is enough to make mental offerings...»

«University of Alberta Evaluation of desiccation-induced oxidative injury in human red blood cells by Tamir Kanias A thesis submitted to the Faculty of Graduate Studies and Research in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Medical Sciences Laboratory Medicine and Pathology ©Tamir Kanias Fall 2010 Edmonton, Alberta Permission is hereby granted to the University of Alberta Libraries to reproduce single copies of this thesis and to lend or sell such...»

<<  HOME   |    CONTACTS
2016 www.dissertation.xlibx.info - Dissertations, online materials

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.